Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 902821, 8 pages
http://dx.doi.org/10.1155/2015/902821
Research Article

Clinical Comparison of QUANTA Flash dsDNA Chemiluminescent Immunoassay with Four Current Assays for the Detection of Anti-dsDNA Autoantibodies

1Immunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, Via Torregalli 3, 50143 Florence, Italy
2Inova Diagnostics, Inc., San Diego, CA 92131, USA
3UO Reumatologia, Ospedale S. Giovanni di Dio, 3055 69321 Firenze, Italy
4UOC Medicina Clinica e Reumatologia, Università Campus Bio-Medico, Via Álvaro del Portillo 21, Roma, Italy
5UOC Reumatologia, Ospedale L. Sacco Polo Universitario, Via Giovanni Battista Grassi 74, 20157 Milano, Italy

Received 24 July 2014; Accepted 17 September 2014

Academic Editor: Ghislain Opdenakker

Copyright © 2015 Maria Infantino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Mahler and M. J. Fritzler, “Epitope specificity and significance in systemic autoimmune diseases,” Annals of the New York Academy of Sciences, vol. 1183, pp. 267–287, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. E. M. Tan, A. S. Cohen, J. F. Fries et al., “The 1982 revised criteria for the classification of systemic lupus erythrematosus,” Arthritis and Rheumatism, vol. 25, no. 11, pp. 1271–1277, 1982. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Petri, A. M. Orbai, G. S. Alarcon et al., “Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus,” Arthritis & Rheumatology, vol. 64, no. 8, pp. 2677–2686, 2012. View at Publisher · View at Google Scholar · View at PubMed
  4. M. Mahler and M. J. Fritzler, “Anti-dsDNA antibody testing in the clinic: farr or ELISA? Commentay,” Nature Clinical Practice Rheumatology, vol. 3, no. 2, pp. 72–73, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. M. Mahler and T. Dervieux, “Comments on recent advances and recommendations for the assessment of autoantibodies to cellular antigens referred as antinuclear antibodies,” Annals of the Rheumatic Diseases, vol. 73, no. 7, article e36, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. D. A. Isenberg, C. Dudeney, W. Williams et al., “Measurement of anti-DNA antibodies: a reappraisal using five different methods,” Annals of the Rheumatic Diseases, vol. 46, no. 6, pp. 448–456, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Agmon-Levin, J. Damoiseaux, C. Kallenberg et al., “International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies,” Annals of the Rheumatic Diseases, vol. 73, no. 1, pp. 17–23, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. M. Mahler, M. J. Fritzler, and M. Blüthner, “Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies,” Arthritis research & Therapy, vol. 7, no. 1, pp. R19–R29, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. C. Bentow, A. Swart, J. Wu et al., “Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens,” Clinica Chimica Acta, vol. 424, pp. 141–147, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. M. Mahler, A. Radice, W. Yang et al., “Development and performance evaluation of novel chemiluminescence assays for detection of anti-PR3 and anti-MPO antibodies,” Clinica Chimica Acta, vol. 413, no. 7-8, pp. 719–726, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. O. Shovman, B. Gilburd, O. Barzilai et al., “Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies,” Annals of the New York Academy of Sciences, vol. 1050, pp. 380–388, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. O. Shovman, B. Gilburd, G. Zandman-Goddard, A. Yehiely, P. Langevitz, and Y. Shoenfeld, “Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases,” Autoimmunity, vol. 38, no. 1, pp. 105–109, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. M. B. Eisen, P. T. Spellman, P. O. Brown, and D. Botstein, “Cluster analysis and display of genome-wide expression patterns,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14863–14868, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Fiegel, A. Buhl, H.-P. Jaekel et al., “Autoantibodies to double-stranded DNA-Intermethod comparison between four commercial immunoassays and a research biosensor-based device,” Lupus, vol. 19, no. 8, pp. 957–964, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. A. A. Venner, D. Ibañez, D. D. Gladman et al., “Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity,” Clinical Biochemistry, vol. 46, no. 4-5, pp. 317–320, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. K. Op De Beéck, P. Vermeersch, P. Verschueren et al., “Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis,” Autoimmunity Reviews, vol. 12, no. 2, pp. 137–143, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. J. G. Hanly, K. Thompson, G. McCurdy, L. Fougere, C. Theriault, and K. Wilton, “Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus,” Journal of Immunological Methods, vol. 352, no. 1-2, pp. 147–152, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. N. Bardin, S. Desplat-Jego, L. Daniel, C. N. Jourde, and M. Sanmarco, “BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus,” Autoimmunity, vol. 42, no. 1, pp. 63–68, 2009. View at Publisher · View at Google Scholar · View at PubMed
  19. T. R. Chiaro, K. W. Davis, A. Wilson, B. Suh-Lailam, and A. E. Tebo, “Significant differences in the analytic concordance between anti-dsDNA IgG antibody assays for the diagnosis of systemic lupus erythematosus—implications for inter-laboratory testing,” Clinica Chimica Acta, vol. 412, no. 11-12, pp. 1076–1080, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. C. Verfaillie, F. de Keyser, and C. Bonroy, “Comparative analysis of 5 different anti-dsDNA assays: performance and correlation with the Farr radioimmunoassay,” in Proceedings of the 9th International Congress on Autoimmunity, Nice, France, 2014.
  21. A. Antico, S. Platzgummer, D. Bassetti, N. Bizzaro, R. Tozzoli, and D. Villalta, “Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test,” Lupus, vol. 19, no. 8, pp. 906–912, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. R. Viriyataveekul, J. Kobkitjaroen, J. Jaiyen, S. Kongkriengdach, and S. Potprasart, “Evaluation of five commercial assays for the detection of anti-dsDNA antibodies: three Crithidia luciliae indirect immunofluorescence test kits and two enzyme immunoassay kits,” Journal of the Medical Association of Thailand: Chotmaihet thangphaet, vol. 97, no. 2, pp. 220–224, 2014. View at Google Scholar · View at Scopus
  23. C. Bentow, A. Seaman, A. Swart, A. Shikhman, N. Goodman, and M. Mahler, “Evaluation of a novel chemiluminescent assay (QUANTA Flash CTD Screen Plus) for the rapid detection of autoantibodies in systemic autoimmune rheumatic diseases,” in Proceedings of the 11th Symposium on Autoantibodies, Dresden, Germany, 2013.
  24. M. Infantino, C. Bentow, A. Seaman et al., “Highlights on novel technologies for the detection of antibodies to Ro60, Ro52, and SS-B,” Clinical and Developmental Immunology, vol. 2013, Article ID 978202, 10 pages, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus